Normal Donor Blood Draws for Platelet Studies and Biomarker Evaluation (ND-PLT)
Status
Conditions
Study type
Funder types
Identifiers
Details and patient eligibility
About
This is a single-center study at the Cleveland Clinic Main Campus designed to study biomarkers in healthy individuals to identify novel mechanisms of platelet activation and how platelets drive vascular inflammation and thrombosis in diseases.
Full description
Our past studies have discovered novel platelet activation pathways that may be targets of therapeutic development. We have also defined an important role for a shift in platelet phenotype in vascular disease. Our studies use both in vivo animal models and validation using human platelets from isolated blood. Platelets from healthy individuals may be compared to patients with vascular diseases in the IRB approved protocol "Vascular Lab Resource" (IRB #19-1451) study which is actively recruiting patients at the Cleveland Clinic Main Campus and studies patients with vascular diseases.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Adults aged 18 to 65 years old
- Healthy Male & Female voluntary participants
Exclusion criteria
- Individuals who have taken anticoagulant or antiplatelet medications in past 10 days
- Individuals with hematopoetic diseases
Trial contacts and locations
Loading...
Central trial contact
Scott Cameron, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal